Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

NCT00190996 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2765

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence, Stress

Interventions

DRUG: Duloxetine Hydrochloride
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]